We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Cardiology

Cardiology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Levothyroxine Treatment and Cardiometabolic Biomarkers in Older Adults with Subclinical Hypothyroidism: A Comprehensive Review
CardiologyLevothyroxine亜臨床性甲状腺機能低下症

Levothyroxine Treatment and Cardiometabolic Biomarkers in Older Adults with Subclinical Hypothyroidism: A Comprehensive Review

By MedXY|Aug 15, 2026

Levothyroxine treatment in older adults with subclinical hypothyroidism shows limited impact on cardiometabolic biomarkers overall but may benefit those with higher TSH levels, highlighting nuanced treatment implications and the need for ta

Personalized Risk Modeling of Interatrial Shunt Therapy in Heart Failure: Insights from the RELIEVE-HF Trial
CardiologyHFpEFinteratrial shunt

Personalized Risk Modeling of Interatrial Shunt Therapy in Heart Failure: Insights from the RELIEVE-HF Trial

By MedXY|Aug 15, 2026

The RELIEVE-HF trial reveals distinct predictors of outcomes after interatrial shunt implantation in HFrEF and HFpEF, enabling personalized risk modeling to identify patients likely to benefit from this therapy.

Long-Term Benefits of Surgical Unroofing in Angina Patients with Myocardial Bridge and Non-Obstructive Coronary Arteries
CardiologyanginaMyocardial Bridge

Long-Term Benefits of Surgical Unroofing in Angina Patients with Myocardial Bridge and Non-Obstructive Coronary Arteries

By MedXY|Aug 15, 2026

Surgical unroofing significantly improves long-term symptoms and quality of life in patients with symptomatic myocardial bridge and non-obstructive coronary arteries refractory to medical therapy.

Acute Effects of Cannabis Inhalation on Cardiac Ectopy, Physical Activity, Sleep, and Glucose: A Synthesis of Clinical Evidence and Mechanistic Insights
Cardiologyrandomized trialcardiac ectopy

Acute Effects of Cannabis Inhalation on Cardiac Ectopy, Physical Activity, Sleep, and Glucose: A Synthesis of Clinical Evidence and Mechanistic Insights

By MedXY|Aug 15, 2026

This review integrates recent randomized trial data with observational studies to clarify cannabis inhalation’s acute impact on cardiac ectopy, physical activity, sleep, and glucose, highlighting complex arrhythmia associations and cl

Unveiling Heart Failure Risks in Newly Diagnosed Diabetes: The Critical Role of Insulin Resistance and Renal Function
Cardiologyepidemiologydiabetes

Unveiling Heart Failure Risks in Newly Diagnosed Diabetes: The Critical Role of Insulin Resistance and Renal Function

By MedXY|Aug 13, 2026

This study reveals a high heart failure risk within 5 years of diabetes diagnosis, highlighting insulin resistance and reduced kidney function as independent predictors beyond conventional risk factors.

Dynamic Metabolic Profiling in Chronic Heart Failure: Insights from Serial NMR Biomarkers and Risk Prediction
Cardiologyrisk stratificationmetabolic biomarkers

Dynamic Metabolic Profiling in Chronic Heart Failure: Insights from Serial NMR Biomarkers and Risk Prediction

By MedXY|Aug 13, 2026

Serial nuclear magnetic resonance metabolic profiling reveals distinct lipid and inflammatory markers predictive of adverse outcomes in chronic heart failure, supporting its role in improving risk stratification.

Oral Anticoagulants, Cognition, and Clinical Outcomes in Atrial Fibrillation and Alzheimer’s Disease: Insights from a Swedish Nationwide Study
CardiologyNOACsoral anticoagulants

Oral Anticoagulants, Cognition, and Clinical Outcomes in Atrial Fibrillation and Alzheimer’s Disease: Insights from a Swedish Nationwide Study

By MedXY|Aug 13, 2026

This review synthesizes evidence linking NOAC use to slower cognitive decline and improved clinical outcomes in patients with atrial fibrillation and Alzheimer’s disease, highlighting advantages over warfarin and non-use.

Rethinking Disease Progression in Transthyretin Amyloid Cardiomyopathy: Toward Mechanism-Specific Monitoring and Therapeutic Response Assessment
Cardiologymechanism-specific therapybiomarker development

Rethinking Disease Progression in Transthyretin Amyloid Cardiomyopathy: Toward Mechanism-Specific Monitoring and Therapeutic Response Assessment

By MedXY|Aug 13, 2026

This article explores a novel, biologically informed framework for monitoring transthyretin amyloid cardiomyopathy progression and treatment, emphasizing mechanism-specific strategies aimed at personalized care.

Progress and Prognostic Insights in Fetal Cardiomyopathy: Findings from a Multicenter North American Cohort
Cardiologyfetal cardiomyopathyfetal hydrops

Progress and Prognostic Insights in Fetal Cardiomyopathy: Findings from a Multicenter North American Cohort

By MedXY|Aug 18, 2026

This multicenter study reveals improved outcomes in fetal cardiomyopathy, highlights genetic underpinnings in one-third of cases, and identifies fetal hydrops and extracardiac anomalies as key prenatal risk factors for mortality.

Vutrisiran Treatment and Cardiovascular MRI-Detected Changes in Cardiac Structure, Function, and Amyloid Burden in ATTR-CM
CardiologyATTR-CMcardiovascular MRI

Vutrisiran Treatment and Cardiovascular MRI-Detected Changes in Cardiac Structure, Function, and Amyloid Burden in ATTR-CM

By MedXY|Aug 18, 2026

Vutrisiran, an RNA interference therapeutic, significantly improves cardiac function, reduces amyloid burden, and attenuates disease progression in transthyretin amyloid cardiomyopathy as revealed by multiparametric cardiovascular MRI and c

Beyond BMI: How Waist Circumference and Waist-to-Hip Ratio Enhance Cardiovascular Risk Prediction
CardiologyBMIcardiovascular risk

Beyond BMI: How Waist Circumference and Waist-to-Hip Ratio Enhance Cardiovascular Risk Prediction

By MedXY|Aug 13, 2026

This analysis reveals that waist circumference and waist-to-hip ratio improve cardiovascular risk classification beyond BMI, identifying individuals with hidden risk and refining prognostic assessments across multiple cardiovascular outcome

Pre-Transplant Left Atrial Volume Index as a Predictor of One-Year Morbidity after Kidney Transplantation: Insights and Implications
CardiologyLeft atrial volume indexLAVI

Pre-Transplant Left Atrial Volume Index as a Predictor of One-Year Morbidity after Kidney Transplantation: Insights and Implications

By MedXY|Aug 12, 2026

This study identifies pre-transplant left atrial volume index as a potential predictor for overall one-year morbidity following kidney transplantation, highlighting its clinical relevance beyond traditional cardiac risk markers.

Unraveling the Mortality Benefits of Beta-Blockers in COPD Patients with Cardiovascular Disease: Influence of LABA Co-therapy
Cardiologycardiovascular diseaseCOPD

Unraveling the Mortality Benefits of Beta-Blockers in COPD Patients with Cardiovascular Disease: Influence of LABA Co-therapy

By MedXY|Aug 12, 2026

A large UK cohort study reveals that beta-blockers reduce mortality in COPD patients with heart failure or ischemic heart disease, but concurrent long-acting beta-agonists may attenuate this benefit.

Decoding Hepatocellular Carcinoma in Fontan-Associated Liver Disease: Genomic and Transcriptomic Insights
CardiologyFontan-associated liver diseasegenomics

Decoding Hepatocellular Carcinoma in Fontan-Associated Liver Disease: Genomic and Transcriptomic Insights

By MedXY|Aug 12, 2026

This article explores the unique genomic and transcriptomic features of hepatocellular carcinoma in Fontan-associated liver disease, revealing distinct mutation patterns and poor-prognosis molecular subtypes that inform disease mechanisms a

AI-Enabled ECG as a New Surveillance Tool for Left Ventricular Dysfunction in Hypertrophic Cardiomyopathy on Mavacamten
AIHypertrophic CardiomyopathyMavacamten

AI-Enabled ECG as a New Surveillance Tool for Left Ventricular Dysfunction in Hypertrophic Cardiomyopathy on Mavacamten

By MedXY|Aug 12, 2026

This study explores the potential of an AI-powered ECG tool to monitor left ventricular systolic dysfunction in hypertrophic cardiomyopathy patients treated with mavacamten, offering a less burdensome alternative to frequent echocardiograms

Unveiling Heart Failure with Preserved Ejection Fraction in Adults with Congenital Heart Disease: Prevalence, Characteristics, and Clinical Challenges
Cardiologycongenital heart diseaseHFpEF

Unveiling Heart Failure with Preserved Ejection Fraction in Adults with Congenital Heart Disease: Prevalence, Characteristics, and Clinical Challenges

By MedXY|Aug 12, 2026

This article explores the high prevalence of heart failure with preserved ejection fraction (HFpEF) in adults with congenital heart disease (ACHD), highlighting its clinical features, hospitalization burden, and under-treatment issues.

Sotatercept’s Multifaceted Role in Enhancing Exercise Capacity in Pulmonary Arterial Hypertension
CardiologyRight Ventricular FunctionOxygen Transport

Sotatercept’s Multifaceted Role in Enhancing Exercise Capacity in Pulmonary Arterial Hypertension

By MedXY|Aug 12, 2026

Sotatercept improves exercise tolerance in pulmonary arterial hypertension through pulmonary vascular remodeling, systemic decongestion with hemoconcentration, improved right ventricular-pulmonary artery coupling, enhanced cardiac output re

Harnessing AI-Enabled ECG for Early Detection of Chagas Disease: A New Frontier in Cardiac Screening
CardiologyECG screeningpublic health

Harnessing AI-Enabled ECG for Early Detection of Chagas Disease: A New Frontier in Cardiac Screening

By MedXY|Aug 12, 2026

A pioneering study shows that AI-enhanced ECG screening combined with epidemiological data can identify undiagnosed Chagas disease cases, improving early detection and care in endemic Brazil.

Evaluating the Clinical and Health Outcomes of Financial Incentives in Hypertension Management: A Comprehensive Review
CardiologyBlood Pressure Controlfinancial incentives

Evaluating the Clinical and Health Outcomes of Financial Incentives in Hypertension Management: A Comprehensive Review

By MedXY|Aug 18, 2026

This review synthesizes evidence on physician-focused financial incentives for hypertension control, highlighting nuanced impacts on clinical decisions, documented blood pressure control, and cardiovascular outcomes, with a focus on both ov

Balancing Stroke and Cardiac Risks: DOACs versus Warfarin in Atrial Fibrillation with Mitral Stenosis
Cardiologyanticoagulation safetymitral stenosis

Balancing Stroke and Cardiac Risks: DOACs versus Warfarin in Atrial Fibrillation with Mitral Stenosis

By MedXY|Aug 11, 2026

This study evaluates the real-world effectiveness and safety of direct oral anticoagulants versus warfarin in Asian patients with atrial fibrillation and mitral stenosis, revealing higher stroke yet lower myocardial infarction risk with DOA

Prev
9 / 25
1…7891011…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles